Add BrightSurf on Google Email

University of Rochester Medical Center


Rochester-led study leads to recommendation for use of heart failure treatment nationwide

A new therapy reduces mortality and heart failure risk in patients with mild cardiac disease, showing a 34% reduction in death or heart failure risk compared to those receiving only an ICD. The treatment has been approved for use in the US, benefiting nearly 4 million Americans with milder forms of heart failure.

SourceUniversity of Rochester Medical Center·JournalNew England Journal of Medicine·DateMar 19, 2010